These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33240994)

  • 21. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical course and its correlated immune status in COVID-19 pneumonia.
    He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
    J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
    Qin C; Zhou L; Hu Z; Zhang S; Yang S; Tao Y; Xie C; Ma K; Shang K; Wang W; Tian DS
    Clin Infect Dis; 2020 Jul; 71(15):762-768. PubMed ID: 32161940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Distribution of peripheral blood lymphocyte subsets in 826 healthy children aged 0-6 years].
    Zhan WL; Yang XH; Guo H; Zhong ZC; DU QY; Zhang CB; Huang BM; Liu H; Luo MY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):180-183. PubMed ID: 30782284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
    Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 31. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
    Rezaei M; Marjani M; Mahmoudi S; Mortaz E; Mansouri D
    Int Arch Allergy Immunol; 2021; 182(3):254-262. PubMed ID: 33498051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.
    Oliveira DC; Spiri BS; Schluga YC; Justus JLP; Lopes Neto FDN; Azambuja AP
    Hematol Transfus Cell Ther; 2023; 45(3):330-337. PubMed ID: 35782909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    Jiang M; Guo Y; Luo Q; Huang Z; Zhao R; Liu S; Le A; Li J; Wan L
    J Infect Dis; 2020 Jun; 222(2):198-202. PubMed ID: 32379887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
    Geng TR; Han Y; Qiu ZF; Du TK; Jiang W; Shi JH; Qin T; Fan HW; Li TS
    Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):200-206. PubMed ID: 32146746
    [No Abstract]   [Full Text] [Related]  

  • 36. TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease.
    Savchenko AA; Tikhonova E; Kudryavtsev I; Kudlay D; Korsunsky I; Beleniuk V; Borisov A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the expression and significance of lymphocyte ratio in different stages and clinical types of COVID-19.
    Xu J; Yao G; Zhang A; Gao H; Yan L
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):132-135. PubMed ID: 38279474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients.
    Liu D; Yuan X; Gao F; Zhao B; Ding L; Huan M; Liu C; Jiang L
    Front Immunol; 2022; 13():899930. PubMed ID: 35865540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic changes of T-lymphocytes and immunoglobulins in patients with severe acute respiratory syndrome].
    National Research Project For SARS Beijing Group Beijing 100020 China
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1014-7. PubMed ID: 12899772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
    Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
    Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.